Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.
about
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategiesUrinary prostaglandin E2 metabolite and breast cancer risk.The role of the insulin-like growth factor-1 system in breast cancerDevelopmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice.Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
P2860
Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@en
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@nl
type
label
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@en
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@nl
prefLabel
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@en
Transgenic insulin-like growth ...... 2 signaling in mammary glands.
@nl
P2093
P2860
P356
P1476
Transgenic insulin-like growth ...... -2 signaling in mammary glands
@en
P2093
Claudio J Conti
Isabel Lambertz
John Digiovanni
Joyce E Rundhaug
Kaoru Kiguchi
Robin Fuchs-Young
Stephanie H Shirley
Susan M Fischer
Thomas R Berton
P2860
P304
P356
10.1002/MC.20868
P50
P577
2011-10-17T00:00:00Z